Literature DB >> 25030896

[Comparison of the OSDI and SPEED questionnaires for the evaluation of dry eye disease in clinical routine].

D Finis1, N Pischel, C König, J Hayajneh, M Borrelli, S Schrader, G Geerling.   

Abstract

BACKGROUND: For the diagnosis of dry eye, taking an accurate medical history of the patient is critical. For this purpose the ocular surface disease index (OSDI) can be regarded as the established standard questionnaire but the standard patient evaluation of eye dryness (SPEED) questionnaire has recently been developed. The advantages of the SPEED questionnaire are the lower number of questions and easier interpretability.
MATERIAL AND METHODS: In a retrospective analysis of 153 patients of our special clinic for dry eyes we performed a comparison of the SPEED with the established OSDI questionnaire regarding the evaluation of the severity of dry eye. In addition, we analyzed possible correlations with various objective parameters for classification of dry eye syndrome.
RESULTS: There was a highly significant correlation between OSDI and SPEED values with a correlation coefficient of 0.47 (p < 0.001). In addition, significant correlations between OSDI values and the tear meniscus height (r = - 0.1374, p = 0.0226), Schirmer values (r = - 0.26, p < 0.0001) and lid margins parallel conjunctival folds (r = 0.1261, p = 0.034) were observed. The SPEED values showed a significant correlation with age (r = - 0.2106, p = 0.0107) and lipid layer thickness (r = - 0.159, p = 0.0081). DISCUSSION: The OSDI and SPEED questionnaires are both suitable for detecting the symptoms of dry eye; however the results of the questionnaires cannot be used interchangeably. While the SPEED levels seemed to correlate more with the parameters of evaporative dry eye, the OSDI values were more correlated with parameters of aqueous tear-deficient dry eye. However, a distinction between evaporative and aqueous tear-deficient dry eye is not possible based only on the results of the questionnaires.

Entities:  

Mesh:

Year:  2014        PMID: 25030896     DOI: 10.1007/s00347-014-3042-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  19 in total

Review 1.  [Meibomian gland dysfunction].

Authors:  D Finis; S Schrader; G Geerling
Journal:  Klin Monbl Augenheilkd       Date:  2012-05-16       Impact factor: 0.700

Review 2.  The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee.

Authors:  Alan Tomlinson; Anthony J Bron; Donald R Korb; Shiro Amano; Jerry R Paugh; E Ian Pearce; Richard Yee; Norihiko Yokoi; Reiko Arita; Murat Dogru
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

3.  Long-term (12-month) improvement in meibomian gland function and reduced dry eye symptoms with a single thermal pulsation treatment.

Authors:  Jack V Greiner
Journal:  Clin Exp Ophthalmol       Date:  2012-12-14       Impact factor: 4.207

Review 4.  Patient-reported symptoms in dry dye disease.

Authors:  Kelly K Nichols
Journal:  Ocul Surf       Date:  2006-07       Impact factor: 5.033

5.  A new system, the LipiFlow, for the treatment of meibomian gland dysfunction.

Authors:  Stephen S Lane; Harvey B DuBiner; Randy J Epstein; Paul H Ernest; Jack V Greiner; David R Hardten; Edward J Holland; Michael A Lemp; James E McDonald; David I Silbert; Caroline A Blackie; Christy A Stevens; Raman Bedi
Journal:  Cornea       Date:  2012-04       Impact factor: 2.651

6.  A single LipiFlow® Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months.

Authors:  Jack V Greiner
Journal:  Curr Eye Res       Date:  2012-02-10       Impact factor: 2.424

7.  Dry eye symptoms assessed by four questionnaires.

Authors:  Trefford L Simpson; Ping Situ; Lyndon W Jones; Desmond Fonn
Journal:  Optom Vis Sci       Date:  2008-08       Impact factor: 1.973

8.  The relationship between dry eye symptoms and lipid layer thickness.

Authors:  Caroline A Blackie; Jessica D Solomon; Robert C Scaffidi; Jack V Greiner; Michael A Lemp; Donald R Korb
Journal:  Cornea       Date:  2009-08       Impact factor: 2.651

9.  Psychometric properties and validation of the Standard Patient Evaluation of Eye Dryness questionnaire.

Authors:  William Ngo; Ping Situ; Nancy Keir; Donald Korb; Caroline Blackie; Trefford Simpson
Journal:  Cornea       Date:  2013-09       Impact factor: 2.651

10.  Comparison of ocular-surface disease index questionnaire, tearfilm break-up time, and Schirmer tests for the evaluation of the tearfilm in computer users with and without dry-eye symptomatology.

Authors:  Cihan Unlü; Esra Güney; Betül İlkay Sezgin Akçay; Gülünay Akçalı; Gürkan Erdoğan; Hüseyin Bayramlar
Journal:  Clin Ophthalmol       Date:  2012-08-10
View more
  12 in total

1.  A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva.

Authors:  Tanima Bose; Aihua Hou; Ryan Lee; Louis Tong; K George Chandy
Journal:  J Vis Exp       Date:  2017-07-05       Impact factor: 1.355

Review 2.  [Diagnosis and treatment of the watering eye].

Authors:  M Schargus; G Geerling
Journal:  HNO       Date:  2017-01       Impact factor: 1.284

3.  Validity of subjective assessment as screening tool for dry eye disease and its association with clinical tests.

Authors:  Kavita R Bhatnagar; Sonali Pote; Sudeep Pujari; Dhiraj Deka
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

4.  Association between Dry Eye Parameters Depends on Tear Components.

Authors:  Shu-Wen Chang; Wan-Lin Wu
Journal:  J Clin Med       Date:  2022-05-28       Impact factor: 4.964

5.  Dermatochalasis Aggravates Meibomian Gland Dysfunction Related Dry Eyes.

Authors:  Wan-Lin Wu; Shu-Wen Chang
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

6.  Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease.

Authors:  Tanima Bose; Ryan Lee; Aihua Hou; Louis Tong; K George Chandy
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

7.  Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity.

Authors:  Xiaodan Jiang; Yuexin Wang; Huibin Lv; Yan Liu; Mingzhou Zhang; Xuemin Li
Journal:  Drug Des Devel Ther       Date:  2018-05-16       Impact factor: 4.162

8.  The effectiveness and safety of moxibustion for dry eye: Protocol for a systematic review.

Authors:  Yingxin Zi; Meiqi Ji; Yu Deng; Yali Qin; Rui Wang; Huan Meng; Ming Jin
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

9.  Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction.

Authors:  Sharlotta Cote; Alexis Ceecee Zhang; Victoria Ahmadzai; Amina Maleken; Christine Li; Jeremy Oppedisano; Kaavya Nair; Ljoudmila Busija; Laura E Downie
Journal:  Cochrane Database Syst Rev       Date:  2020-03-18

10.  Vitamin D Supplementation for Patients with Dry Eye Syndrome Refractory to Conventional Treatment.

Authors:  Seok Hyun Bae; Young Joo Shin; Ha Kyoung Kim; Joon Young Hyon; Won Ryang Wee; Shin Goo Park
Journal:  Sci Rep       Date:  2016-10-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.